Zobrazeno 1 - 10
of 11 731
pro vyhledávání: '"LONG-TERM TREATMENT"'
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 9, Pp 2645-2652 (2024)
Abstract Introduction The efficacy and safety of tildrakizumab for the treatment of plaque psoriasis were demonstrated by randomized clinical studies, but the reappraisal of prolonged experiences in the clinical practice helps to optimize the use of
Externí odkaz:
https://doaj.org/article/b428056128db4741bbf3c2c6950d88a8
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 14, Iss 2, Pp 35-41 (2024)
Relevance. Tension-free herniolasty of the anterior abdominal wall is currently the accepted standard for large ventral hernia repairing. The implementation of this approach has been marked by a significant improvement in treatment outcomes. The issu
Externí odkaz:
https://doaj.org/article/f719c8b665334f6f9cda252aa44f09f1
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
IntroductionChronic and inappropriate benzodiazepine (BDZ) prescription and intake represent an important health and social concern worldwide. The aim of our study was to investigate the safety and efficacy of P. incarnata L., herba in reducing BDZ m
Externí odkaz:
https://doaj.org/article/e07b0b4882a94ef6bcac94cba92963c5
Autor:
Piero Barbanti, Gabriella Egeo, Stefania Proietti, Florindo d’Onofrio, Cinzia Aurilia, Cinzia Finocchi, Laura Di Clemente, Maurizio Zucco, Alberto Doretti, Stefano Messina, Massimo Autunno, Angelo Ranieri, Antonio Carnevale, Bruno Colombo, Massimo Filippi, Miriam Tasillo, Steno Rinalduzzi, Pietro Querzani, Giuliano Sette, Lorenzo Forino, Francesco Zoroddu, Micaela Robotti, Alessandro Valenza, Cecilia Camarda, Laura Borrello, Marco Aguggia, Giovanna Viticchi, Carlo Tomino, Giulia Fiorentini, Bianca Orlando, Stefano Bonassi, Paola Torelli, for the Italian Migraine Registry study group
Publikováno v:
Neurology and Therapy, Vol 13, Iss 3, Pp 611-624 (2024)
Abstract Introduction Long-term (1-year) fremanezumab treatment proved to be effective, safe, and well tolerated in individuals with migraine and 3 treatment failures and various comorbidities. Methods A 48-week, prospective, multicenter (n = 26), co
Externí odkaz:
https://doaj.org/article/466e8ed5e5ca4896b88d65d5aed29347
Autor:
Andrew Östör, Filip Van den Bosch, Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion, Kyle Carter, Vassilis Stakias, Ralph Lippe, Leonidas Drogaris, Ahmed M. Soliman, Michael M. Chen, Byron Padilla, Alan Kivitz
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 633-648 (2024)
Abstract Introduction Long-term therapeutic options providing durable response and tolerability are needed for psoriatic arthritis (PsA). The ongoing KEEPsAKE 2 trial is evaluating risankizumab treatment in patients with active PsA who previously had
Externí odkaz:
https://doaj.org/article/9ce4042ecece4341be994d1a7b7901c4
Autor:
Lars Erik Kristensen, Mauro Keiserman, Kim Papp, Leslie McCasland, Douglas White, Kyle Carter, Ralph Lippe, Huzefa Photowala, Leonidas Drogaris, Ahmed M. Soliman, Michael Chen, Byron Padilla, Frank Behrens
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 617-632 (2024)
Abstract Introduction Patients with psoriatic arthritis (PsA) require treatment providing durable long-term efficacy in different disease domains as well as safety. We present 100-week efficacy and safety results of risankizumab in patients with acti
Externí odkaz:
https://doaj.org/article/d175f505a9724186801cfc38fbee94d1
Autor:
Moritz Z. Kayser, Hendrik Suhling, Jan Fuge, Christopher A. Hinze, Nora Drick, Nikolaus Kneidinger, Jürgen Behr, Christian Taube, Tobias Welte, Ina Haasler, Katrin Milger
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Monoclonal antibodies (biologics) drastically changed severe asthma therapy. Mepolizumab (anti-interleukin (IL) 5), benralizumab (anti-IL5 receptor alpha), and dupilumab (anti-IL4/13) are the most used biologics in this context. W
Externí odkaz:
https://doaj.org/article/9b65f82e70434ca195edfb5cf288a4e3
Autor:
Francesco La Torre, Silvia Vannuccini, Federico Toscano, Ernesto Gallucci, Gretha Orlandi, Virginia Manzi, Felice Petraglia
Publikováno v:
Gynecological Endocrinology, Vol 40, Iss 1 (2024)
AbstractBackground Dienogest (DNG) improves endometriosis-associated pain (EAP) and patients’ quality of life; however, the modern cornerstone of the management of endometriosis is the long-term adherence of the patient to medical treatment.Objecti
Externí odkaz:
https://doaj.org/article/e102e64c32cb4ba7bd22a9c46cddc0ca
Autor:
Alexander Armstrong, Huong Ho, Mark Tacey, Damien Bolton, Yee Chan, Alwin Tan, Chee Wee Cham, Trung Pham, Kevin McMillan, George Koufogiannis, Paul Manohar, Mario Guerrieri, Michael Ng, Daryl Lim Joon, Farshad Foroudi, Mun Yee Tan, Michael Chao
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 16, Iss 1, Pp 6-11 (2024)
Externí odkaz:
https://doaj.org/article/cfa23a2511dc4589aa9fd0266cc61112
Autor:
Fabrizio Vernieri, Luigi Francesco Iannone, Simona Guerzoni, Antonio Russo, Piero Barbanti, Grazia Sances, Sabina Cevoli, Renata Rao, Carlo Lovati, Anna Ambrosini, Carlotta Buzzoni, Federico Battisti, Laura Vatteone, Steffy Martin Luther King, Federico Torelli
Publikováno v:
Neurology and Therapy, Vol 13, Iss 2, Pp 415-435 (2024)
Abstract Background Galcanezumab is approved in the European Union (EU) as migraine prophylaxis in adults with at least four migraine days per month. The aim of this retrospective observational study was to evaluate the long-term effectiveness of gal
Externí odkaz:
https://doaj.org/article/867499ace621443f8405bbefa697c514